Plain-English translation of NCT07743749 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study uses artificial intelligence to analyze MRI images of kidney tumors and help doctors better understand what type of tumor a patient has and how aggressive it might be. Researchers will use data from patients who have already had kidney MRI scans and surgery to train and test computer models that can recognize different tumor patterns. The goal is to make it easier for doctors to plan the right treatment before surgery.
Currently, doctors can have difficulty accurately identifying the exact type of kidney tumor and how serious it is just by looking at standard MRI images. This study exists to develop smarter computer tools that can analyze these images in ways humans might miss, helping doctors make better treatment decisions and improve outcomes for kidney cancer patients.
You likely qualify if…
You likely don't qualify if…
This is not an active treatment study—you would not need to do anything new. Researchers would use MRI scans and medical records you already had as part of your regular kidney cancer care. Your imaging data and pathology results would be de-identified (your name and personal information removed) and used to help train and test artificial intelligence models. No additional appointments, tests, or treatments are required.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China